BCM
RVPH

BluePointe Capital Management’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

BluePointe Capital Management’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$45K Buy
2,359
+1,840
+355% +$57.8K 0.02% 128
2024
Q4 		$18.8K Hold
519
– – 0.01% 94
2024
Q3 		$14.9K Hold
519
– – 0.01% 88
2024
Q2 		$13.3K Hold
519
– – 0.01% 86
2024
Q1 		$39.2K Hold
519
– – 0.03% 87
2023
Q4 		$53.4K Buy
+519
New +$46.6K 0.04% 87

Other funds holding RVPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $242M AUM 182.75% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return